SIU 2018: American Urological Association Lecture - Bladder Exstrophy: Global Solutions for a Global Problem

Seoul, South-Korea (UroToday.com) Congenital anomalies are important causes of infant and childhood deaths, chronic illness and disability. In the 63rd world health assembly in 2010, a consensus was reached to improve the health of children with congenital anomalies by:

  • Developing and strengthening registration and surveillance systems
  • Developing expertise and building capacity
  • Strengthening research and studies on etiology, diagnosis, and prevention
  • Promoting international cooperation

SIU 2018: Conservative Management in Upper Urinary Tract Transitional Cell Carcinoma

Seoul, South-Korea (UroToday.com) In the third talk of the UTUC session, Makarand Khochikar, MD provided a summary and expert recommendations for conservative management of upper tract urothelial carcinoma (UTUC).  For a long time, the standard of care for UTUC has been radical nephroureterectomy, for a few reasons:

SIU 2018: Diagnosis and Staging: The Pitfalls and the Challenges of Upper Urinary Tract Transitional Cell Carcinoma

Seoul, South-Korea (UroToday.com) Jean de la Rosette, MD provided the second talk in this course focusing on the diagnosis and staging of upper tract urothelial carcinoma (UTUC), with an emphasis on pitfalls and challenges.  The key points being highlighted below.

SIU 2018: Is it an Aggressive Disease? Upper Urinary Tract Transitional Cell Carcinoma

Seoul, South-Korea (UroToday.com) Makarand Khochikar, MD in place of the scheduled Dr. Pruthi, kicked off the session on upper tract urothelial carcinoma (UTUC) by focusing on the topic of UTUC aggressiveness.  He briefly introduced some basic demographic and clinical presentation information, the key points are listed below.

SIU 2018: Adjuvant Therapy After Radical Nephroureterectomy: Where Is the Evidence

Seoul, South-Korea (UroToday.com) Badrinath Konety, MD as the final speaker in the UTUC instructional course, focused on the role of adjuvant therapy for UTUC after nephroureterectomy (RNU).  First and foremost, the difficulty in assessing the quality of studies already completed in this area (for perioperative chemotherapy) is that there are:

SIU 2018: MRI Should Be Performed in All Patients Before Biopsy: Bladder Sparing Surgery – PRO

Seoul, South-Korea (UroToday.com) This session began with a case presentation of a 76-year-old man with muscle-invasive bladder cancer (MIBC). This was a generally healthy man with mild hypertension, who had macroscopic painless hematuria, and was diagnosed with MIBC after transurethral resection of a bladder tumor (TURBT).  Dr. Umbas gave his point of view on supporting bladder-sparing treatment for this patient instead of radical cystectomy.

SIU 2018: MRI Should Be Performed in All Patients Before Biopsy: Bladder Sparing Surgery – CON

Seoul, South-Korea (UroToday.com) This session began with a case presentation of a 76-year-old man with muscle-invasive bladder cancer (MIBC). This was a generally healthy man with mild hypertension, who had macroscopic painless hematuria, and was diagnosed with MIBC after transurethral resection of a bladder tumor (TURBT). Badrinath Konety, MD presented his point of view, on why this patient should undergo radical cystectomy, which is the gold standard treatment for a patient with MIBC.
E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe